[Retracted] The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis

<div>Network diagram of included articles ((a) is the OS network diagram, (b) is the PFS network diagram). A total of 16 papers presented their findings on OS, including 5 involving erlotinib and CTX, 6 involving gefitinib and CTX, 2 involving afatinib and CTX, 2 involving cetuximab and CTX, and 1 involving icotinib and CTX.</div>

Disease Markers

fig2

Figure 2

Figure 2: [Retracted] The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis 